TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD Analyst Ratings

• Total Analysts: 1
• Consensus Rating: Hold
• Price Target: $5.00
• Upside: +152.53%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Louise Chen Cantor Fitzgerald	Cantor Fitzgerald	Hold Reiterates $5	Hold	Reiterates	$5	+152.53%	Aug 17, 2023
Louise Chen Cantor Fitzgerald	Cantor Fitzgerald	Hold Initiates $5	Hold	Initiates	$5	+152.53%	Jan 11, 2023
Louise Chen Cantor Fitzgerald	Cantor Fitzgerald	Hold Reiterates $1	Hold	Reiterates	$1	-49.49%	Jul 13, 2022
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades $10	Strong Buy → Hold	Downgrades	$10	+405.05%	Jun 7, 2022
Louise Chen Cantor Fitzgerald	Cantor Fitzgerald	Buy → Hold Downgrades $250 → $50	Buy → Hold	Downgrades	$250 → $50	+2,425.25%	May 6, 2022
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $150 → $125	Strong Buy	Maintains	$150 → $125	+6,213.13%	Mar 11, 2022
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Nov 12, 2021
Chris Howerton Jefferies	Jefferies	Hold → Sell Downgrades n/a	Hold → Sell	Downgrades	n/a	n/a	Aug 7, 2020
Chris Schott JP Morgan	JP Morgan	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	May 19, 2020
Annabel Samimy Stifel	Stifel	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Apr 16, 2020
William Tanner Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Aug 14, 2018
Esther Rajavelu Deutsche Bank	Deutsche Bank	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Jul 21, 2017
Jay Olson Oppenheimer	Oppenheimer	Hold → Buy Upgrades n/a	Hold → Buy	Upgrades	n/a	n/a	Jul 11, 2017
Jay Olson Oppenheimer	Oppenheimer	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	May 9, 2017
Annabel Samimy Stifel	Stifel	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Dec 6, 2016